Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lemonnier

Showing results (251-260 of 264) with videos related to

Pageof 27
Sort By:
Immunity|August 6, 1999
Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptorsT Hanke, H Takizawa, C W McMahon, et al.
Oncology Reports|February 3, 2007
Induction of multiple CD8+ T cell responses against the inducible Hsp70 employing an Hsp70 oligoepitope peptideOlivier Faure, Stéphanie Graff-Dubois, Pedro M S Alves, et al.
European Journal of Immunology|October 30, 1999
H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategiesH Firat, F Garcia-Pons, S Tourdot, et al.
Human Immunology|June 3, 2004
Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cellsPierre S Rohrlich, Sylvain Cardinaud, Jacqueline Lulè, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
IL-4 confers NK stimulatory capacity to murine dendritic cells: a signaling pathway involving KARAP/DAP12-triggering receptor expressed on myeloid cell 2 moleculesMagali Terme, Elena Tomasello, Koji Maruyama, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2002
HER-2/neu and hTERT cryptic epitopes as novel targets for broad spectrum tumor immunotherapyAntonio Scardino, David-Alexandre Gross, Pedro Alves, et al.
Diabetes|September 22, 2012
HLA-B7-restricted islet epitopes are differentially recognized in type 1 diabetic children and adults and form weak peptide-HLA complexesMatthieu Scotto, Georgia Afonso, Thomas Østerbye, et al.
Cancer Research|July 20, 2007
A polyepitope DNA vaccine targeted to Her-2/ErbB-2 elicits a broad range of human and murine CTL effectors to protect against tumor challengeAntonio Scardino, Maurizio Alimandi, Pierpaolo Correale, et al.
The Journal of Clinical Investigation|February 3, 2004
High vaccination efficiency of low-affinity epitopes in antitumor immunotherapyDavid-Alexandre Gross, Stéphanie Graff-Dubois, Paule Opolon, et al.
International Journal of Cancer|January 9, 2004
Inducible Hsp70 as target of anticancer immunotherapy: Identification of HLA-A*0201-restricted epitopesOlivier Faure, Stéphanie Graff-Dubois, Laurent Bretaudeau, et al.
Pageof 27

Showing results (251-260 of 264) with videos related to

Sort By:
Pageof 27
Immunity|August 6, 1999
Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptorsT Hanke, H Takizawa, C W McMahon, et al.
Oncology Reports|February 3, 2007
Induction of multiple CD8+ T cell responses against the inducible Hsp70 employing an Hsp70 oligoepitope peptideOlivier Faure, Stéphanie Graff-Dubois, Pedro M S Alves, et al.
European Journal of Immunology|October 30, 1999
H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategiesH Firat, F Garcia-Pons, S Tourdot, et al.
Human Immunology|June 3, 2004
Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cellsPierre S Rohrlich, Sylvain Cardinaud, Jacqueline Lulè, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
IL-4 confers NK stimulatory capacity to murine dendritic cells: a signaling pathway involving KARAP/DAP12-triggering receptor expressed on myeloid cell 2 moleculesMagali Terme, Elena Tomasello, Koji Maruyama, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2002
HER-2/neu and hTERT cryptic epitopes as novel targets for broad spectrum tumor immunotherapyAntonio Scardino, David-Alexandre Gross, Pedro Alves, et al.
Diabetes|September 22, 2012
HLA-B7-restricted islet epitopes are differentially recognized in type 1 diabetic children and adults and form weak peptide-HLA complexesMatthieu Scotto, Georgia Afonso, Thomas Østerbye, et al.
Cancer Research|July 20, 2007
A polyepitope DNA vaccine targeted to Her-2/ErbB-2 elicits a broad range of human and murine CTL effectors to protect against tumor challengeAntonio Scardino, Maurizio Alimandi, Pierpaolo Correale, et al.
The Journal of Clinical Investigation|February 3, 2004
High vaccination efficiency of low-affinity epitopes in antitumor immunotherapyDavid-Alexandre Gross, Stéphanie Graff-Dubois, Paule Opolon, et al.
International Journal of Cancer|January 9, 2004
Inducible Hsp70 as target of anticancer immunotherapy: Identification of HLA-A*0201-restricted epitopesOlivier Faure, Stéphanie Graff-Dubois, Laurent Bretaudeau, et al.
Pageof 27